Editas Medicine (EDIT) Change in Accured Expenses (2015 - 2025)
Editas Medicine (EDIT) reported Change in Accured Expenses of -$543000.0 for Q3 2025, down 153.5% year-over-year from $1.0 million in Q3 2024, and down 193.94% on a QoQ basis from $578000.0 in Q2 2025.
Editas Medicine (EDIT) has 11 years of Change in Accured Expenses data on file, last reported at -$543000.0 in Q3 2025.
- Quarterly Change in Accured Expenses fell 153.5% year-over-year to -$543000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $8.5 million (up 327.56% YoY) and the FY2024 annual result came in at $1.3 million, down 29.39% from the prior year.
- Change in Accured Expenses retreated to -$543000.0 in Q3 2025 per EDIT's latest filing, from $578000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $6.8 million in Q4 2024 and bottomed at -$9.6 million in Q1 2021.
- The 5-year median for Change in Accured Expenses is $531500.0 (2022), against an average of $35166.7.
- The widest annual swing landed in 2021, when Change in Accured Expenses soared 1905.82%; it then sank 153.83% in 2023.
- Tracing EDIT's Change in Accured Expenses over 5 years: stood at $5.3 million in 2021, then tumbled by 90.8% to $485000.0 in 2022, then soared by 266.6% to $1.8 million in 2023, then jumped by 282.11% to $6.8 million in 2024, then tumbled by 107.99% to -$543000.0 in 2025.
- Per Business Quant, the three latest EDIT Change in Accured Expenses figures stand at -$543000.0 (Q3 2025), $578000.0 (Q2 2025), and $1.7 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -543,000.00 |
| Sep 30, 2025 | -543,000.00 |
| Jun 30, 2025 | 578,000.00 |
| Jun 30, 2025 | 578,000.00 |
| Mar 31, 2025 | 1.69 Mn |
| Mar 31, 2025 | 1.69 Mn |
| Dec 31, 2024 | 6.79 Mn |
| Dec 31, 2024 | 6.79 Mn |
| Sep 30, 2024 | 1.02 Mn |
| Sep 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | -3.84 Mn |
| Jun 30, 2024 | -3.84 Mn |
| Mar 31, 2024 | -2.69 Mn |
| Mar 31, 2024 | -2.69 Mn |
| Dec 31, 2023 | 1.78 Mn |
| Dec 31, 2023 | 1.78 Mn |
| Sep 30, 2023 | 2.38 Mn |
| Sep 30, 2023 | 2.38 Mn |
| Jun 30, 2023 | -2.36 Mn |
| Jun 30, 2023 | -2.36 Mn |
| Dec 31, 2022 | 485,000.00 |
| Dec 31, 2022 | 485,000.00 |
| Sep 30, 2022 | -887,000.00 |
| Sep 30, 2022 | -887,000.00 |
| Jun 30, 2022 | 4.38 Mn |
| Jun 30, 2022 | 4.38 Mn |
| Mar 31, 2022 | -3.98 Mn |
| Mar 31, 2022 | -3.98 Mn |
| Dec 31, 2021 | 5.27 Mn |
| Dec 31, 2021 | 5.27 Mn |
| Sep 30, 2021 | -3.42 Mn |
| Sep 30, 2021 | -3.42 Mn |
| Jun 30, 2021 | 3.55 Mn |
| Jun 30, 2021 | 3.55 Mn |
| Mar 31, 2021 | -9.56 Mn |
| Mar 31, 2021 | -9.56 Mn |
| Dec 31, 2020 | -292,000.00 |
| Dec 31, 2020 | -292,000.00 |
| Sep 30, 2020 | 10.05 Mn |
| Sep 30, 2020 | 10.05 Mn |
| Jun 30, 2020 | 1.21 Mn |
| Jun 30, 2020 | 1.21 Mn |
| Mar 31, 2020 | -13.64 Mn |
| Mar 31, 2020 | -13.64 Mn |
| Dec 31, 2019 | 6.14 Mn |
| Dec 31, 2019 | 6.14 Mn |
| Sep 30, 2019 | 136,000.00 |
| Sep 30, 2019 | 136,000.00 |
| Jun 30, 2019 | -5.51 Mn |
| Jun 30, 2019 | -5.51 Mn |
| Mar 31, 2019 | 881,000.00 |
| Mar 31, 2019 | 881,000.00 |
| Dec 31, 2018 | 1.70 Mn |
| Dec 31, 2018 | 1.70 Mn |
| Sep 30, 2018 | 312,000.00 |
| Sep 30, 2018 | 312,000.00 |
| Jun 30, 2018 | 3.28 Mn |
| Jun 30, 2018 | 3.28 Mn |
| Mar 31, 2018 | -1.25 Mn |
| Mar 31, 2018 | -1.25 Mn |
| Sep 30, 2017 | -8.96 Mn |
| Sep 30, 2017 | -8.96 Mn |
| Jun 30, 2017 | -6.20 Mn |
| Jun 30, 2017 | -6.20 Mn |
| Mar 31, 2017 | -10.54 Mn |
| Mar 31, 2017 | -10.54 Mn |
| Dec 31, 2016 | 7.81 Mn |
| Dec 31, 2016 | 7.81 Mn |
| Sep 30, 2016 | 1.90 Mn |
| Sep 30, 2016 | 1.90 Mn |
| Jun 30, 2016 | 320,000.00 |
| Jun 30, 2016 | 320,000.00 |
| Mar 31, 2016 | 1.81 Mn |
| Mar 31, 2016 | 1.81 Mn |
| Dec 31, 2015 | 2.70 Mn |
| Dec 31, 2015 | 2.70 Mn |
| Sep 30, 2015 | 540,000.00 |
| Sep 30, 2015 | 540,000.00 |
| Jun 30, 2015 | -580,000.00 |
| Jun 30, 2015 | -580,000.00 |
| Mar 31, 2015 | 863,000.00 |
| Mar 31, 2015 | 863,000.00 |